Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schultz Swings The Cleaver At Teva, Cutting 25% Of The Workforce

Dec 14 2017

• By Jessica Merrill

Desperate businessmen

Related Content

Generic Manufacturers Try To Up Their Game As US Pressure Persists

Jun 16 2017

Teva Lands A CEO: Can Schultz Replicate Lundbeck Success?

Sep 11 2017

Teva Offloads Women's Health Business To Two Firms For $1.38Bn

Sep 18 2017

A New Regime Takes The Reins At Teva

Nov 27 2017

Related Companies

Teva Pharmaceutical Industries Ltd.

H. Lundbeck A/S

Allergan plc

Additional Topics

Generic Drugs Business Strategies Leadership Companies Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.